Correction: Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
Michael J. Bond, Craig M. Crews
TL;DR
This paper corrects a previously published article on the development and progress of proteolysis targeting chimeras (PROTACs) in targeted protein degradation.
Contribution
The paper provides corrections to the original article published in RSC Chemical Biology.
Findings
The paper corrects errors in the original publication.
It ensures the scientific community has accurate information on PROTACs.
Abstract
Correction for ‘Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation’ by Michael J. Bond et al., RSC Chem. Biol., 2021, 2, 725–742, https://doi.org/10.1039/D1CB00011J.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1- —American Cancer Society10.13039/100000048
- —National Institute of General Medical Sciences10.13039/100000057
- —National Cancer Institute10.13039/100000054
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProtein Degradation and Inhibitors · Click Chemistry and Applications · Histone Deacetylase Inhibitors Research
The authors regret that an incorrect version of Fig. 4 was included in the original article which labelled Bordoxalone as an Irreversible covalent E3 ligase recruiting element (E3RE), when Bordoxalone should have been labelled as a Reversible covalent E3RE. This was stated correctly in the main text. The correct version of Fig. 4 is presented below.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.